WIDDER KENNETH J - 27 May 2022 Form 4 Insider Report for QUIDEL CORP /DE/

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jun 2022, 16:26:21 UTC
Prior SEC filing
20 May 2022
Next SEC filing
08 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip S. Askim, attorney-in-fact for Kenneth J. Widder

Key filing fact

WIDDER KENNETH J filed Form 4 for QUIDEL CORP /DE/ on 01 Jun 2022.

Key facts

  • This page summarizes WIDDER KENNETH J's Form 4 filing for QUIDEL CORP /DE/.
  • 11 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 01 Jun 2022, 16:26.

Change

  • Previous filing in this sequence was filed on 20 May 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QDEL transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-18,684
Change %
-100%
Price
Shares after
0
Date
27 May 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QDEL transaction Derivative

Non-Qualified Stock Options

Disposed to Issuer

Transaction value
$0
Shares
-3,333
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,333
Exercise price
$27.91
Footnotes
F2, F3
QDEL transaction Derivative

Non-Qualified Stock Options

Disposed to Issuer

Transaction value
$0
Shares
-7,021
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,021
Exercise price
$22.86
Footnotes
F2, F3
QDEL transaction Derivative

Non-Qualified Stock Options

Disposed to Issuer

Transaction value
$0
Shares
-7,021
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,021
Exercise price
$15.74
Footnotes
F2, F3
QDEL transaction Derivative

Non-Qualified Stock Options

Disposed to Issuer

Transaction value
$0
Shares
-5,065
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,065
Exercise price
$24.80
Footnotes
F2, F3
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-1,050
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,050
Exercise price
Footnotes
F4, F5, F6
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-315
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
315
Exercise price
Footnotes
F4, F5, F6
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-328
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
328
Exercise price
Footnotes
F4, F5, F6
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-98
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
98
Exercise price
Footnotes
F4, F5, F6
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-512
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
512
Exercise price
Footnotes
F4, F5, F6
QDEL transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
$0
Shares
-153
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
153
Exercise price
Footnotes
F4, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

WIDDER KENNETH J is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 6 footnotes

Footnote F1

Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.

Footnote F2

Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F3

Vested in full.

Footnote F4

Each restricted stock unit represents the right to receive one share of Quidel common stock.

Footnote F5

Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

Footnote F6

Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .